Mycenax is the pioneer of biologics in Taiwan. We are the leader in the process development and drug development field. Furthermore, we explore our brand awareness and business services to the European and American market in recent years.
Mycenex establishes the comprehensive biologics drug development platform with international standards. In addition to providing services for the development of new biological drugs, Mycenax is now successfully integrating technology, regulations, and project management capabilities to develop the biological drugs that conform to the ICH guideline. We are the first plant in Taiwan with US FDA master file registration at the Jhunan Biotechnology Park, we obtain Accreditation of Foreign Manufacturer in Japan, and our factory is PIC/S GMP certified in Taiwan.
Mycenax provides CMC based CDMO total solution for our global partner.